Why is Amanta Healthcare Ltd ?
1
Weak Long Term Fundamental Strength with a -2.00% CAGR growth in Net Sales over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.35 times
2
Flat results in Sep 25
- NO KEY NEGATIVE TRIGGERS
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
-2.00%
EBIT Growth (5y)
9.30%
EBIT to Interest (avg)
1.30
Debt to EBITDA (avg)
3.27
Net Debt to Equity (avg)
1.99
Sales to Capital Employed (avg)
0.80
Tax Ratio
28.62%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.34%
ROCE (avg)
13.97%
ROE (avg)
8.18%
Valuation Key Factors 
Factor
Value
P/E Ratio
38
Industry P/E
34
Price to Book Value
1.88
EV to EBIT
11.62
EV to EBITDA
8.04
EV to Capital Employed
1.63
EV to Sales
1.75
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
14.03%
ROE (Latest)
4.98%
Loading Valuation Snapshot...






